JP2021525776A5 - - Google Patents

Info

Publication number
JP2021525776A5
JP2021525776A5 JP2020567613A JP2020567613A JP2021525776A5 JP 2021525776 A5 JP2021525776 A5 JP 2021525776A5 JP 2020567613 A JP2020567613 A JP 2020567613A JP 2020567613 A JP2020567613 A JP 2020567613A JP 2021525776 A5 JP2021525776 A5 JP 2021525776A5
Authority
JP
Japan
Prior art keywords
compound according
pharmaceutical composition
formula
compound
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567613A
Other languages
English (en)
Japanese (ja)
Other versions
JP7527977B2 (ja
JP2021525776A (ja
Filing date
Publication date
Priority claimed from IT102018000005987A external-priority patent/IT201800005987A1/it
Application filed filed Critical
Publication of JP2021525776A publication Critical patent/JP2021525776A/ja
Publication of JP2021525776A5 publication Critical patent/JP2021525776A5/ja
Application granted granted Critical
Publication of JP7527977B2 publication Critical patent/JP7527977B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567613A 2018-06-04 2019-05-31 眼疾患の治療における使用のための、フォトクロミック化合物 Active JP7527977B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102018000005987 2018-06-04
IT102018000005987A IT201800005987A1 (it) 2018-06-04 2018-06-04 Composti fotocromici
PCT/IB2019/054530 WO2019234567A1 (en) 2018-06-04 2019-05-31 Photochromic compounds for use in the treatment of eye disorders

Publications (3)

Publication Number Publication Date
JP2021525776A JP2021525776A (ja) 2021-09-27
JP2021525776A5 true JP2021525776A5 (enExample) 2022-06-03
JP7527977B2 JP7527977B2 (ja) 2024-08-05

Family

ID=63312371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567613A Active JP7527977B2 (ja) 2018-06-04 2019-05-31 眼疾患の治療における使用のための、フォトクロミック化合物

Country Status (5)

Country Link
US (1) US11401250B2 (enExample)
EP (1) EP3802491B1 (enExample)
JP (1) JP7527977B2 (enExample)
IT (1) IT201800005987A1 (enExample)
WO (1) WO2019234567A1 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH490460A (de) * 1966-05-27 1970-05-15 Ciba Geigy Verfahren zur Herstellung neuer basischer Azofarbstoffe
US3666746A (en) * 1969-06-25 1972-05-30 Gaf Corp Pyrrolidonylphenyl azo dyestuffs
JP4161583B2 (ja) * 2002-02-07 2008-10-08 コニカミノルタホールディングス株式会社 偏光板の製造方法
EP2214660A2 (en) * 2007-10-12 2010-08-11 Resolvyx Pharmaceuticals, Inc. Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions
WO2010051343A1 (en) 2008-10-31 2010-05-06 The Regents Of The University Of California Photoreactive synthetic regulator of protein function and methods of use thereof
CN104230746B (zh) 2014-08-14 2015-12-02 毕宏生 一种化学光转化物及其制备方法和用途

Similar Documents

Publication Publication Date Title
US11040035B2 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
US11459312B2 (en) Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides
US11591311B2 (en) 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
JP2021535112A5 (enExample)
JP2022081661A5 (enExample)
JP2014506582A5 (enExample)
JP2008531715A (ja) 統合失調症及び関連疾患の治療用及び／又は予防用の医薬組成物
RU2007116119A (ru) Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
BR112017016193B1 (pt) Derivados de 4h-pirrolo[3,2-c]piridin-4-ona
JP2006506466A5 (enExample)
JP2005530811A5 (enExample)
JP2009537550A5 (enExample)
JP2008514732A5 (enExample)
JP2011513475A5 (enExample)
JP2022501370A5 (enExample)
US20200289509A1 (en) 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor anatgonists
JP2020512337A5 (enExample)
JP2018513190A5 (enExample)
JP2008538741A (ja) 鬱病の治療用及び／又は予防用の医薬組成物
EP2455080A1 (en) S1P1 receptor agonists for use in the treatment of multiple sclerosis
US9441000B2 (en) Use of metallocene compounds for cancer treatment
JP2021503449A5 (enExample)
JP2010522714A (ja) 新規な医薬組成物
RU2018101473A (ru) Депо-препарат, содержащий сложный эфир лимонной кислоты
JP2010514733A5 (enExample)